ERBB2 and neoplasm: NGS (YucoOne® Pro+ panel; depth 2134.4×; tumor content 55%) confirmed ERBB2 amplification (copy number 37.3), indicating HER2 heterogeneity from primary (1+) to metastasis (3+) (Figure 1).